Drug Shortage Report for DILAUDID HP

Last updated on 2020-03-23 History
Report ID 12731
Drug Identification Number 00622133
Brand name DILAUDID HP
Common or Proper name Hydromorphone Hydrochloride, 10mg/mL
Company Name PURDUE PHARMA
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 1 mL ampoules
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2017-06-13
Actual start date 2017-06-13
Estimated end date 2017-12-31
Actual end date 2017-12-31
Shortage status Resolved
Updated date 2020-03-23
Company comments Inventory Constraints. Dilaudid tablets and oral solution available
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-03-23 French Compare
v6 2020-03-23 English Compare
v5 2017-06-14 English Compare
v4 2017-06-13 French Compare
v3 2017-06-13 English Compare
v2 2017-06-13 French Compare
v1 2017-06-13 English Compare

Showing 1 to 7 of 7